| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |